Brief: PCI Biotech Holding: AstraZeneca Not To Enter Into Definitive Agreement For FimaNAc Technology
Oct 21 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* ASTRAZENECA HAS ELECTED NOT TO ENTER INTO A DEFINITIVE
AGREEMENT
FOR FIMANAC TECHNOLOGY
* DECISION NOT TO ENTER INTO A DEFINITIVE AGREEMENT IS
PRIMARILY
BASED ON A STRATEGIC EVALUATION OF CURRENT DEVELOPMENT NEEDS
* COMPANIES PLAN TO WORK TOGETHER TO PUBLISH PRECLINICAL
RESULTS
FROM THIS COLLABORATION
Source text for Eikon: ID:nGNEbpmm6W
Further company coverage: PCIB.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process